Reviews
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
BOC Sciences
Inotuzumab | BOC Sciences
Inotuzumab (brand name Besponsa) is a monoclonal antibody used in the treatment of certain types of leukemia. Inotuzumab specifically targets CD22, a protein expressed on the surface of B-cell lymphoblasts in acute lymphoblastic leukemia (ALL) and other B-cell malignancies. By binding to CD22, Inotuzumab interferes with cell signaling pathways involved in cell growth and survival, ultimately leading to cell death. Inotuzumab is indicated for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor ALL. It is used when other treatments have not been effective or when the disease has returned after previous treatment.
More Scientific Products from BOC Sciences
![Anti-PRAME antibody [EPR20330]](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJjb21wYW55X3Byb2R1Y3RfcHJvZmlsZV9pbWFnZV9mMzEwNTY4MGY1NmVmZjU3ZjZhMWRkZTU2M2Q4YjBmODZjMDJkNDE4XzMwMDA3MTg1ODEyLmpwZyIsImVkaXRzIjp7InRvRm9ybWF0IjoianBnIiwicmVzaXplIjp7IndpZHRoIjozMDAsImhlaWdodCI6MzAwLCJmaXQiOiJjb3ZlciIsInBvc2l0aW9uIjoiY2VudGVyIiwiYmFja2dyb3VuZCI6IiNmZmYifSwiZmxhdHRlbiI6eyJiYWNrZ3JvdW5kIjoiI2ZmZiJ9fX0=)
-
NOV 04, 2025The Simple Way to Protein Research -
NOV 05, 2025xMAP Connect 2025 Virtual Series
-
NOV 06, 2025Precision Oncology Showcase
- See More
Opens in a new window
Opens an external site
Opens an external site in a new window